Gross Profit On Sales تغيير تاريخ
3M USD 3.34B 401M 2023-12
Abbott USD 5.68B 147M 2023-12
AngioDynamics USD 40.06M 6.3M 2023-06
AtriCure USD 79.82M 5.95M 2023-12
Baxter International USD 1.49B 351M 2023-12
Becton, Dickinson and Co. USD 2.03B 326M 2023-12
Boston Scientific USD 2.57B 135M 2023-12
Cooper Companies USD 606.5M 3.5M 2023-09
Dexcom USD 673.2M 49.9M 2023-12
Edwards Lifesciences USD 1.18B 46.7M 2023-12
Globus Medical USD 351.05M 102.8M 2023-12
Haemonetics USD 184.93M 14.36M 2023-12
Hologic USD 567.5M 67.2M 2023-12
ICU Medical USD 171.58M 12.34M 2023-12
Insulet USD 361.2M 67.9M 2023-12
Integra LifeSciences USD 239.24M 14.93M 2023-12
J&J USD 14.6B 374M 2023-12
Merit Medical Systems USD 142.2M 10.58M 2023-09
Olympus JPY 151.21B 13.99B 2023-09
Pfizer USD 7.58B 3.26B 2023-12
STAAR Surgical USD 60.72M 2.91M 2023-12
Stryker USD 3.71B 535M 2023-12
Surmodics USD 20.93M 24.63M 2023-09
Tandem Diabetes Care USD 93.3M 3.54M 2023-12
Teleflex USD 431.42M 15.11M 2023-12
Terumo JPY 118.46B 8.66B 2023-09
Zimmer Biomet Holdings USD 1.4B 166.3M 2023-12



Merit Medical Systems الربح الإجمالي على المبيعات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2024.